“Is there a pharmacotherapy specialist in the house?”
This Clinical Grand Rounds is designed for participants to gain a deeper knowledge of the role of a pharmacotherapy specialist in palliative care, and how an evidence-based practice application (the old three-legged stool) is implemented. What does the term “pharmacotherapy” mean? The official definition is “the treatment of disease through the administration of drugs.” How does this fit in a palliative care model? This definition can be expanded to include not only the selection of medications to treat disease, but also deprescribing, switching to therapeutic alternatives, applying evidence to drug therapy decision making, and using appropriate communication techniques around the pharmacotherapeutic process. Participants in this session will gain a deeper understanding of the role of a pharmacotherapy specialist in palliative care, and how an evidence-based practice (the old three-legged stool) is implemented!
*Note: A recording of this live webinar will be available in Q1 of 2024
Hospice Medical Directors
At the conclusion of this activity the participant will be able to:
1. Discern the incorporation of the pharmacotherapy specialist’s skill set into the care planning process to improve outcomes in caring for patients with a serious illness (and their families).
2. Incorporate “evidence-based practice” in palliative pharmacotherapy and reflect on illustrative examples for future practice application.
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.
All editors, faculty and staff have disclosed no relevant financial relationships.
*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients.
Mary Lynn McPherson, PharmD MA MDE BCPS FAAHPM
Julie Tanner, BSN RN-BC CHPN
Julie Bruno, MSW LCSW
Julie Tanner, BSN RN-BC CHPN
Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Hospice and Palliative Medicine (AAHPM) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion includes attesting to meaningful activity participation and completion/submission of activity evaluation within the time frame designated.
Evaluation period closes June 30, 2023 at 11:59 PM PCT for claiming CME credit.
Maintenance of Certification (MOC) Recognition Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, “Is there a pharmacotherapy specialist in the house?” applies toward general CME requirement for the following ABMS Member Boards:
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
• This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org for a list of all MOCA 2.0 requirements.
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn 1.0 credits toward the CME of the American Board of Surgery’s Continuous Certification program.
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit. By submitting your evaluation, you grant AAHPM permission to submit completion information to ACCME for the purpose of granting respective BOARD MOC program credit or points as applicable.
Evaluation period closes June 30, 2023 at 11:59 PM PCT for claiming MOC credit.
- 1.00 ABA MOC
- 1.00 ABIM MOC
- 1.00 ABP MOC
- 1.00 ABS MOC
- 1.00 CME (physician only)